Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02699970 · ClinicalTrials.gov registry record
Instrument Precision Study for Validation of Philips Dx
A clinical trial of Pathology, sponsored by Philips Digital & Computational Pathology.
- Completed
- Registry status
- 399
- Enrollment target
- 1
- Study location
NCT02699970 is a study of Pathology that has completed, run by Philips Digital & Computational Pathology. The registered enrollment target is 399 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02699970, a study of Pathology, has completed, sponsored by Philips Digital & Computational Pathology.
- COMPLETED
- Registry status
- 399 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to evaluate precision of the Philips Dx system.
Conditions Studied
Study Locations (1)
Massachusetts
- MGH - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 399 participants |
| Start Date | 2016-02 |
| Est. Completion | 2016-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02699970
The ClinicalTrials.gov registry entry for NCT02699970 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 399 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Philips Digital & Computational Pathology, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pathology appearing as the primary indexed condition, and to 0 interventions.
NCT02699970 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02699970 about?
NCT02699970 is a clinical study titled "Instrument Precision Study for Validation of Philips Dx". The objective of this study is to evaluate precision of the Philips Dx system.
What is the current status of trial NCT02699970?
This trial is currently completed. The enrollment target is 399 participants. The study started on 2016-02. Estimated completion is 2016-10.
What conditions does trial NCT02699970 study?
This clinical trial studies the following conditions: Pathology.
Who is sponsoring clinical trial NCT02699970?
This trial is sponsored by Philips Digital & Computational Pathology, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02699970 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pathology
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.